Association of longitudinal alcohol consumption trajectories with coronary heart disease: a meta-analysis of six cohort studies using individual participant data

Abstract

BackgroundStudies have shown that alcohol intake trajectories differ in their associations with biomarkers of cardiovascular functioning, but it remains unclear if they also differ in their relationship to actual coronary heart disease (CHD) incidence. Using multiple longitudinal cohort studies, we evaluated the association between long-term alcohol consumption trajectories and CHD.MethodsData were drawn from six cohorts (five British and one French). The combined analytic sample comprised 35,132 individuals (62.1% male; individual cohorts ranging from 869 to 14,247 participants) of whom 4.9% experienced an incident (fatal or non-fatal) CHD event. Alcohol intake across three assessment periods of each cohort was used to determine participants’ intake trajectories over approximately 10 years. Time to onset for (i) incident CHD and (ii) fatal CHD was established using surveys and linked medical record data. A meta-analysis of individual participant data was employed to estimate the intake trajectories' association with CHD onset, adjusting for demographic and clinical characteristics.ResultsCompared to consistently moderate drinkers (males: 1–168 g ethanol/week; females: 1–112 g ethanol/week), inconsistently moderate drinkers had a significantly greater risk of incident CHD [hazard ratio (HR) = 1.18, 95% confidence interval (CI) = 1.02–1.37]. An elevated risk of incident CHD was also found for former drinkers (HR = 1.31, 95% CI = 1.13–1.52) and consistent non-drinkers (HR = 1.47, 95% CI = 1.21–1.78), although, after sex stratification, the latter effect was only evident for females. When examining fatal CHD outcomes alone, only former drinkers had a significantly elevated risk, though hazard ratios for consistent non-drinkers were near identical. No evidence of elevated CHD risk was found for consistently heavy drinkers, and a weak association with fatal CHD for inconsistently heavy drinkers was attenuated following adjustment for confounding factors.ConclusionsUsing prospectively recorded alcohol data, this study has shown how instability in drinking behaviours over time is associated with risk of CHD. As well as individuals who abstain from drinking (long term or more recently), those who are inconsistently moderate in their alcohol intake have a higher risk of experiencing CHD. This finding suggests that policies and interventions specifically encouraging consistency in adherence to lower-risk drinking guidelines could have public health benefits in reducing the population burden of CHD. The absence of an effect amongst heavy drinkers should be interpreted with caution given the known wider health risks associated with such intake.Trial registrationClinicalTrials.gov, NCT03133689.Electronic supplementary materialThe online version of this article (10.1186/s12916-018-1123-6) contains supplementary material, which is available to authorized users.

Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population

“…It has been reported that the dose of alcohol is associated with the biological effect on diabetes and cardiovascular diseases [30]. Thus, it is believed that lower alcohol intake may be beneficial to maintaining metabolic health and reducing cardiovascular disease risk [31]. No statistically significant association was found between cigarette smoking and metabolic status in normal weight individuals.…”

Association of thirty-year alcohol consumption typologies and fatty liver: Findings from a large population cohort study

“…When an individual reported low-risk or heavy drinking on an equal number of occasions, participants were assigned to the unstable heavy drinking group. Participants were permitted one missing alcohol value during follow-up (O'Neill et al, 2018).…”

Alcohol consumption may not affect the diameter of the coronary arteries in men with chest pain

“…Studies have shown that alcohol exerts protective effects against risk factors for atherosclerosis, such as hypertension, a high body mass index (BMI), and an increased level of high-density lipoprotein cholesterol (HDL-c); improves endothelial function; increases insulin sensitivity; and reduces fasting insulin resistance. 3,4 Many studies have focused on the formation of atherosclerotic plaques, but few studies have focused on changes in artery diameter. An increased coronary artery diameter may be associated with a reduced severity of CHD.…”